1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. 2019; Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 144:1941–53. DOI:
10.1002/ijc.31937. PMID:
30350310.
Article
2. Choi KS, Yoon M, Song SH, Suh M, Park B, Jung KW, et al. 2018; Effect of mammography screening on stage at breast cancer diagnosis: results from the Korea National Cancer Screening Program. Sci Rep. 8:8882. DOI:
10.1038/s41598-018-27152-3. PMID:
29892094. PMCID:
PMC5995898.
Article
3. Lee EH, Park B, Kim NS, Seo HJ, Ko KL, Min JW, et al. 2015; The Korean guideline for breast cancer screening. J Korean Med Assoc. 58:408–19. DOI:
10.5124/jkma.2015.58.5.408.
Article
4. D'Orsi CJ. 2013. ACR BI-RADS Atlas: Breast Imaging Reporting and Data System. 5th ed. American College of Radiology;Reston:
5. Lazarus E, Mainiero MB, Schepps B, Koelliker SL, Livingston LS. 2006; BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value. Radiology. 239:385–91. DOI:
10.1148/radiol.2392042127. PMID:
16569780.
Article
6. Itoh A, Ueno E, Tohno E, Kamma H, Takahashi H, Shiina T, et al. 2006; Breast disease: clinical application of US elastography for diagnosis. Radiology. 239:341–50. DOI:
10.1148/radiol.2391041676. PMID:
16484352.
Article
7. Lakhani SR. 2012. WHO Classification of Tumours of the Breast. 4th ed. International Agency for Research on Cancer;Lyon:
8. Yoon JH, Kim MJ, Moon HJ, Kwak JY, Kim EK. 2011; Subcatego-rization of ultrasonographic BI-RADS category 4: positive predictive value and clinical factors affecting it. Ultrasound Med Biol. 37:693–9. DOI:
10.1016/j.ultrasmedbio.2011.02.009. PMID:
21458145.
Article
9. Kim EK, Ko KH, Oh KK, Kwak JY, You JK, Kim MJ, et al. 2008; Clinical application of the BI-RADS final assessment to breast sonography in conjunction with mammography. AJR Am J Roentgenol. 190:1209–15. DOI:
10.2214/AJR.07.3259. PMID:
18430833.
Article
10. Elverici E, Barça AN, Aktaş H, Özsoy A, Zengin B, Çavuşoğlu M, et al. 2015; Nonpalpable BI-RADS 4 breast lesions: sonographic findings and pathology correlation. Diagn Interv Radiol. 21:189–94. DOI:
10.5152/dir.2014.14103. PMID:
25835079. PMCID:
PMC4463260.
Article
11. Li FS, Bai BY, Wang YM, Xiao Y, Song CX, Song ZJ, et al. 2017; Sonographic features of dense breast imaging reporting and data system 4 (BI-RADS-US4) for non-palpable breast lesions. Int J Clin Exp Med. 10:10806–12.
12. Costantini M, Belli P, Lombardi R, Franceschini G, Mulè A, Bonomo L. 2006; Characterization of solid breast masses: use of the sonographic breast imaging reporting and data system lexicon. J Ultrasound Med. 25:649–59. quiz 661DOI:
10.7863/jum.2006.25.5.649. PMID:
16632790.
13. Mohamed RE, Abo-Dewan KA. 2014; Incremental value of real-time ultrasound elastography in differentiating breast masses. Egypt J Radiol Nucl Med. 45:605–18. DOI:
10.1016/j.ejrnm.2014.01.006.
Article
14. Ikeda K, Ogawa Y, Takii M, Sugano K, Ikeya T, Tokunaga S, et al. 2012; A role for elastography in the diagnosis of breast lesions by measuring the maximum fat lesion ratio (max-FLR) by tissue Doppler imaging. Breast Cancer. 19:71–6. DOI:
10.1007/s12282-011-0274-5. PMID:
21567172.
Article
15. Crystal P, Strano SD, Shcharynski S, Koretz MJ. 2003; Using sonography to screen women with mammographically dense breasts. AJR Am J Roentgenol. 181:177–82. DOI:
10.2214/ajr.181.1.1810177. PMID:
12818853.
Article
16. Lee HJ, Kim EK, Kim MJ, Youk JH, Lee JY, Kang DR, et al. 2008; Observer variability of Breast Imaging Reporting and Data System (BI-RADS) for breast ultrasound. Eur J Radiol. 65:293–8. DOI:
10.1016/j.ejrad.2007.04.008. PMID:
17531417.
Article
17. Stavros AT, Rapp CL, Parker SH. 2004. Breast Ultrasound. Lippincott Williams & Wilkins;Philadelphia: